personalized medicine – AI.RadicalShift

interviewsVery Long Interview with Grok 3 on AI: The Great Handover: How AI is Reshaping Our World

Accelerated computing, Agent AI, AI assistants, AI models, Algorithms, Americas, Artificial Intelligence, Augmented reality, Automotive, Autonomous driving, Aviation & Aerospace, Chemicals, Datasets, Deep learning, Defence, Edge AI, Edge computing, Electronics & Machinery, Energy, Gas & Oil, Entertainment, Environment, Financial, Gaming, Generative AI, Graph neural network (GNN), Graphics Processing Unit (GPU), Healthcare, Internet & Online, LLMs (Large Language Models), Machine learning, Natural language processing (NLP), Neural networks, Pharma & Biotech, Quantum Computing, Science, Security & Safety, Semiconductors

March 14, 2025

Oleg Lazarov

2nm chips, Adobe’s AI, agentic AI, AGI, AI, AIVA’s tracks, Apple M-series, Apple’s Neural Engine, Apple’s Secure Enclave, AR, AutoGPT, automation, AWS SageMaker, biases, Black Box Blues, brain-computer interfaces (BCI), brain-signal-to-text, cancer patients, carbon-neutral cities, Cerebras, chain-of-thought, chain-of-thought reasoning, chiplets, CLIP, convolutional neural networks, creative collaboration, creativity, data synthesis, decision trees, decision-making, deep learning, Drug Discovery, Duolingo, edge AI, Edge chips, Education, energy efficiency, EU AI Act, Explainable AI, FedAvg, federated learning, generative adversarial networks (GANs), Georgia State’s AI system, GitHub, Google, Google’s DeepMind, Google’s VideoLLM, GPT-4, GPUs, Grok, Grok 3, Grok’s Toolkit, H200, hallucinations, Healthcare, high bandwidth memory (HBM3), HIPAA compliance, homomorphic encryption, human oversight, IBM, IBM Watson Health, IBM’s AI Fairness 360, innovation, Jasper, jobocalypse, Khan Academy, linear regression, LLMs, machine learning, March 14 2025, Meta, Meta’s SeamlessM4T, Microsoft’s Copilot, Midjourney, Mixture of Experts, modern AI, MS COCO, multimodal AI, natural language processing (NLP), Nest, neural networks, neuromorphic processors, No Man’s Sky, NVIDIA’s DLSS, NVIDIA’s Jetson, NVLink, OpenAI o1, OpenAI’s GPT-4o, Pepsi, personalized medicine, Pfizer, predictive models, privacy, PyTorch, Qualcomm Snapdragon, quantum computing, Rain Neuromorphics, reasoning algorithms, reasoning models, Reinforcement Learning from Human Feedback, remote work, RL, RLHF, robotics, RunwayML, Sakana AI, scientific discovery, self-driving cars, sepsis onset, SHAP, Siemens’ edge solutions, simulations, Slack, Smell data, softmax weights, support vector machines, sustainability, Sycamore, synthetic data, Tempus, TensorFlow, Tesla’s Full Self-Driving chips, TinyML, touch data, TPUs, traditional ML, transformers, TSMC, upskilling, ViT, VQA, VR, Wafer-Scale Engine, wearables, XAI

This interview with Grok, conducted between March 14 and 18, 2025, explored the multifaceted radical shifts AI is driving across the globe, reflecting RadicalShift.AI’s mission to obsessively observe these changes. We traversed a vast landscape—starting with AI’s implications for intellectual property, where it blurs ownership and challenges legal norms, to its ethical quandaries in military…
Continue Reading
newsEuropean Society of Cardiology Spearheads NextGen Project: Revolutionizing Cardiovascular Health with AI-Powered Precision Medicine

Analytics, Artificial Intelligence, Europe, Healthcare, Pharma & Biotech

February 12, 2024

Sheryl Rivera

AI, artificial intelligence, cardiovascular disease, CVD, ESC, European Society of Cardiology, genetic analysis, Horizon Europe program, NextGen project, personalized medicine, precision medicine, Professor Panos Deloukas, Professor Pim van der Harst, Queen Mary University of London, SMEs, University Medical Center Utrecht

SOPHIA ANTIPOLIS — The European Society of Cardiology (ESC), a leading nonprofit organization dedicated to reducing the burden of cardiovascular disease (CVD), has announced the launch of the NextGen project aimed at transforming CVD treatment through the power of artificial intelligence (AI). With a substantial €7.6 million grant from the EU’s Horizon Europe program, the…
Continue Reading
newsFraunhofer-Gesellschaft Unveils AI-Powered Healthcare Solutions at DMEA 2023, Revolutionizing Patient Care

Augmented reality, Education, Europe, Healthcare

April 6, 2023

Sheryl Rivera

affordable care, aging population, AI, AI-based, Algorithms, artificial intelligence, automated processing, breast cancer, clinical research management, diagnosis, Digital Solutions, early detection, Education, Efficiency, Fraunhofer Center for Assistive Information and Communication Solutions AICOS, Fraunhofer Center for Digital Diagnostics, Fraunhofer Institute for Applied Information Technology FIT, Fraunhofer Institute for Cognitive Systems IKS, Fraunhofer Institute for Computer Graphics Research IGD, Fraunhofer Institute for Digital Medicine MEVIS, Fraunhofer Institute for Integrated Circuits IIS. Important words: DMEA 2023, Fraunhofer Institute for Intelligent Analysis and Information Systems IAIS, Fraunhofer-Gesellschaft, Germany, Healthcare, healthcare solutions, innovative AI, interoperable health data spaces, IT infrastructure, management, National Research Center for Applied Cybersecurity ATHENE, personalized medicine, precise diagnoses, Prevention, quantum computing, rehabilitation, secure digitalization, streamlined processes, therapy, transparent

MUNICH — Fraunhofer-Gesellschaft, a renowned German research organization, unveils cutting-edge digital solutions for the healthcare sector at DMEA 2023 in Berlin. The event serves as a platform for the organization to spotlight advancements in AI-based technologies aimed at revolutionizing patient care, diagnostics, and therapy, according to a press release published on EuropaWire . The healthcare…
Continue Reading
newsAI Revolutionizes Drug Discovery with Predictive Models for Effective Combinations

AI assistants, Algorithms, Americas, Analytics, Artificial Intelligence, Healthcare, Internet & Online, Machine learning, Pharma & Biotech

April 17, 2021

Oleg Lazarov

AI in medicine, AI-powered tools, biomedical research, cancer treatment, Compositional Perturbation Autoencoder, CPA, drug combinations, Drug Discovery, Facebook AI, gene expression, Helmholtz Zentrum München, machine learning, personalized medicine, pharmaceutical innovation, single-cell RNA sequencing

MENLO PARK — In a groundbreaking development, Facebook AI, in collaboration with Helmholtz Zentrum München, has introduced an innovative AI model designed to accelerate the discovery of effective drug combinations for complex diseases. This new model, known as the Compositional Perturbation Autoencoder (CPA), represents a significant advancement in the field of computational drug discovery, enabling…
Continue Reading
newsFacebook AI Unveils Breakthrough Model to Accelerate Discovery of Life-Saving Drug Combinations

Algorithms, Americas, Analytics, Artificial Intelligence, Europe, Healthcare, Open Source LLMs, Pharma & Biotech

April 16, 2021

Oleg Lazarov

academic researchers, AI-driven method, AI-powered tools, biological systems, biomedical research, cancer cells, cancer treatment, complex diseases, Compositional Perturbation Autoencoder, COVID-19, CPA model, drug combinations, Drug Discovery, drug interactions, drug optimization, drug repurposing, Facebook AI, gene alterations, gene expression, Helmholtz Zentrum München, in silico, machine learning, open-source tool, personalized medicine, pharmaceutical labs, pharmaceutical research, RNA sequencing, single-cell RNA sequencing

MENLO PARK — In a groundbreaking development, a new AI-driven method has been introduced to fast-track the discovery of effective drug combinations to combat complex diseases. Developed by Facebook AI in collaboration with Helmholtz Zentrum München, the Compositional Perturbation Autoencoder (CPA) model aims to predict the effects of drug combinations, dosages, and timing, while also…
Continue Reading
newsRoche Introduces Breakthrough Automated Digital Pathology Algorithm for Non-Small Cell Lung Cancer Diagnosis

Algorithms, Analytics, Artificial Intelligence, Europe, Pharma & Biotech

June 26, 2020

Sheryl Rivera

artificial intelligence, automated digital pathology algorithm, cancer diagnostics, CE-IVD launch, clinical image analysis, diagnostic consistency, digital pathology solution, Healthcare, hematoxylin and eosin-stained slides, image analysis, immunohistochemistry, in situ hybridization, lung cancer, non-small cell lung cancer diagnosis, NSCLC, objective, pathology decision support, personalized healthcare, personalized medicine, Pharma & Biotech, reproducible, Roche, Switzerland, targeted treatment options, technology, Thomas Schinecke, tissue staining, tumour cell staining positivity, uPath enterprise software, uPath PD-L1 (SP263), VENTANA PD-L1, whole-slide automated analysis

BASEL – Roche, a global leader in pharmaceuticals and diagnostics, has unveiled a groundbreaking automated digital pathology algorithm designed to revolutionize the diagnosis of non-small cell lung cancer (NSCLC). Developed to assist pathologists in the identification and measurement of tumor cell staining positivity, the uPath PD-L1 (SP263) image analysis promises faster and more accurate diagnoses,…
Continue Reading

What is RadicalShift AI?

RadicalShift.ai represents the paradigm shift the artificial intelligence (AI) brings upon all of us, from the way we live and work to the way we do business. To help cope with these fundamental changes across life, industries and the world in general, we are obsessively observing (30+ markets across multiple continents) and covering the AI industry while building a scalable open platform aimed at people, businesses and industry stakeholders to contribute across (benefit from) the entire spectrum of the AI industry from news, views, insights to knowledge, deployments, entities, people, products, tools, jobs, investors, pitch decks, and beyond, helping build what would potentially be a resourceful, insightful, knowledgeable and analytical source for AI related news, information and resources, ultimately becoming the AI industry graph/repository.